[email protected]

Author: Khyati Patel

Pharma Audits

Pharma Audits

Third‑Party PV Subcontractors in the Crosshairs: How to Audit‑Proof Your Vendor Agreements

March 10, 2026 No Comments

GVP Module Updated

GVP Audits

GVP Module IX Update in Q2 2026: What’s Changing and How to Prepare Now

March 5, 2026 No Comments

Pharmacovigilance Regulations

Pharmacovigilance Services

Signal Management Overhaul: How to Adapt Your SOPs After the Deletion of Article 21(2)

March 3, 2026 No Comments

ESMP Compliance

Pharmacovigilance Services

ESMP Compliance in 2026: EMA Pharmacovigilance & Shortage Reporting Essentials

February 26, 2026 No Comments

GMP Inspections

GVP Audits

Unannounced FDA GMP Inspections: Readiness Guide for Foreign Facilities

February 24, 2026 No Comments

Risk-Based Vendor Audit Strategies

Risk-Based Audits

ICH E6(R3) & CRO Oversight: Risk-Based Vendor Audit Strategies

February 19, 2026 No Comments

Pharmacovigilance services

Pharmacovigilance Services

EU Pharmacovigilance Regulation 2025/1466: GvP Vendor Audit Essentials Before Feb 2026

February 17, 2026 No Comments

FDA Warning Letter support

Pharma Audits

Why 87% of FDA Warning Letters Require External GMP Consultants

February 12, 2026 No Comments

GDP Compliance Support

Risk-Based Audits

GDP Compliance Support for Pharmaceutical Wholesalers Under Inspection

February 10, 2026 No Comments

GMP inspection readiness

Pharmacovigilance Services

CAPA Remediation Support After Regulatory Inspections

February 5, 2026 No Comments

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

CONTACT US

[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting